CD44 is a marker of endocervical neoplasia

International Journal of Gynecological Pathology

Volumn 18, Issue 2, 1999, Pages 101-108

  Ibrahim, Emad M ^a,b   Blackett, Anthony D ^b   Tidy, John A ^b   Wells, Michael ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

CD44; Ervical carcinoma; Immunohistochemistry

Indexed keywords

HERMES ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

EID: 0033025114     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199904000-00001     Document Type: Article

References (51)

1. Anton-Culver H, Bloss JD, Bringman D, Lee-Feldstein A, DiSaia P, Manetta A. Comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: a population-based epidemiologic study. Am J Obstet Gynecol 1992;166:1507-14.
2. Vesterinen E, Forss M, Nieminen U. Increase of cervical adenocarcinoma: a report of 520 cases of cervical carcinoma including 112 tumors with glandular elements. Gynecol Oncol 1989;33:49-53.
3. Hopkins MP, Morley GW. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 1991;77: 912-7.
4. Leminen A, Paavonen J, Forss M, Wahlstrom T, Vesterinen E. Adenocarcinoma of the uterine cervix. Cancer 1990;65:53-9.
5. Stuart GCE, Mcgregor SE, Duggan MA, Nation JG. Review of the screening history of Alberta women with invasive cervical cancer. Can Med Assoc J 1997;157:513-9.
6. Ollayos CW. Update on the Papanicolaou smear: new issues for the 1990s. Mil Med 1997;162:521-3.
7. Young RH, Clement PB. Pseudoneoplastic glandular lesions of the uterine cervix. Semin Diagn Pathol 1991;8:234-19.
8. Young RH, Scully RE. Atypical forms of microglandular hyperplasia of the cervix simulating carcinoma. Am J Surg Pathol 1989;13:50-6
9. Aruffo A, Samenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61:1303-13.
10. Stamenkovic I, Amiot M, Pesando JM, Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989;56:1057-62.
11. Seth A, Gote L, Nagarkatti M, Nagarkatti PS. T-cell receptor independent activation of cytotoxic activity of cytotoxic lymphocytes mediated through CD44 and gp90MEL-14. Proc Natl Acad Sci USA 1991;88:7877-81.
12. Hardwick C, Hoare K, Owens R, et al. Molecular cloning of a novel hyaluronan receptor that mediates tumour cell motility. J Cell Biol 1992;117:1343-50.
13. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development . J Exp Med 1994;180:53-66.
14. Reber S, Marzku S, Gunther U, Ponta H, Herrlich P, Zoller M. Retardation of metastatic tumour growth after immunization with metastasis specific monoclonal antibodies. Int J Cancer 1990;46: 919-27.
15. Gunthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24.
16. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992;89:12160-4.
17. Tanabe KK, Nishi T, Saya H. Novel variants of CD44 arising from alternative splicing changes in the CD44 alternative splicing pattern of MCF-7 breast carcinoma cells treated with hyaluronidase. Mol Carcinogen 1993;7:212-20.
18. Tolg C, Hofman M, Herrlich P, Ponta H. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 1993;21:1225-9.
19. Jackson DG, Buckley J, Bell JI. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 1992;267: 4732-9.
20. Nagasaka S, Tanabe KK, Bruner JM, Saya H, Sawaya RE, Morrison RS. Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors. J Neurosurg 1995;82:858-63.
21. Rudy W, Hofmann M, Schwartz R, et al. Two major CD44 proteins expressed on a metastatic rat tumour cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res 1993;53:1262-8.
22. Terpe HJ, Koopmann R, Imhof BA, Gunthert U. Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas. J Pathol 1994;174:89-100.
23. Joensuu H, Klemi PJ, Toikkanen S, Jalkanen S. Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol 1993;143:867-74.
24. Sugino T, Gorham H, Yoshida K, et al. Progressive loss of CD44 gene expression in invasive bladder cancer. Am J Pathol 1996; 148:873-82.
25. Noordzij MA, van Steenbrugge G-J, Verkaik NS, Schroder JH, van der Kwast TH. The prognostic value of CD44 isoforms in prostatic cancer patients treated by radical prostatectomy. Clin Cancer Res 1997;3:805-15.
26. Dall P, Heider K-J, Hekele A, et al. Surface protein expression and mRNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res 1994;54:3337-11.
27. Shimabukuro K, Yoyamo-Sorimachi N, Ozaki Y, et al. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer. Gynecol Oncol 1997;64:26-34.
28. Soukka T, Salmi M, Joensuu H, et al. Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells. Cancer Res 1997;57:2281-9.
29. Hudson DL, Speight PM, Watt FM. Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them. Int J Cancer 1996;66:457-63.
30. Sasaki JI, Tanabe KK, Iakahashi K, et al. Expression of CD44 splicing isoforms in lung cancers: dominant expression of CD44v8-10 in non-small cell lung carcinomas. Int J Oncol 1998; 12:525-33.
31. Dellas A, Schultheiss E, Almendral AC, Torhost J, Gudat F. Expression of CD44 and variant isoforms in cervical intraepithelial neoplasia. Gynecol Oncol 1996;62:218-25.
32. Herold-Mende C, Seiter S, Born A, et al. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J Pathol 1996;179:66-73.
33. McCluggage WG, Maxwell P, McBride HA, Hamilton PW, Bharucha H. Monoclonal antibodies Ki-67 and MIB1 in the distinction of tuboendometrial metaplasia from endocervical adenocarcinoma and adenocarcinoma in situ in formalin fixed material. Int J Gynecol Pathol 1995;14:209-16.
34. Van Hoeven KH, Ramondetta L, Kovatich AJ, Marluce B, Dunton CJ. Quantitative image analysis of MIB-1 reactivity in inflammatory, hyperplastic and neoplastic endocervical lesions. Int J Gynecol Pathol 1997;16:15-21.
35. Rollason TP, Byrne P, Williams A, Brown G. Expression of epithelial membrane and 3-fucosyl-N-acetyllactosamine antigens in cervix uteri particular reference to adenocarcinoma in situ. J Clin Pathol 1988;41:547-52.
36. Liao SY, Brewer C, Zavada J, et al. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol 1994;145:598-609.
37. Brown LJ, Griffin NR, Wells M. Cytoplasmic reactivity with the monoclonal antibody HMFG1 as a marker of cervical glandular atypia. J Pathol 1987;151:203-8.
38. Yoshida K, Bolideoku J, Sugino T, et al. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumours. Cancer Res 1995;55:4273-7.
39. Saegusa M, Hashimura M, Okayasu I. CD44 expression in normal, hyperplastic, and malignant endometrium. J Pathol 1998;184:297-306.
40. Smedts F, Ramaekers F, Troyanovsky S, et al. Keratin expression in cervical cancer. Am J Pathol 1992;141:497-511.
41. Senzaki H, Ogura E, Iwamoto S, et al. Keratin expression in normal uterine cervical epithelium and carcinomas of cervical origin. Oncol Reports 1997;4:79-83.
42. Ikegami A, Kato J. Keratin expression in normal cervical epithelium, cervical intraepithelial neoplasia and cervical cancer. Acta Histochem Cytochem 1996;29:51-6.
43. Meyer R. Eie epsdithelentwicklung der cervix and porto vaginalis uteri und die pseudoerosio cogenita. Arch Gynak 1910;91: 579-83.
44. Fluhmann CE. Comparative studies of squamous metaplasia of the cervix uteri and endometrium. Am J Obstet Gynecol 1954;68: 1447-51
45. Song J. The Human Uterus: Morphogenesis and Embryological Basis for Cancer. Springfield, IL: Charles C. Thomas, 1964.
46. Reid VL, Singer A, Coppleson M. The process of cervical regeneration after electrocauterization: histochemical, autoradiographic and pH study. Ausf N Z J Obstet Gynaecol 1967;7:125-32.
47. Lawrence WD, Shingleton HM. Early physiologic squamous metaplasia of the cervix: light and electron microscopic observations. Am J Obstet Gynecol 1980;15:661-71.
48. Weikel W, Wagner R, Moll R. Characterization of subcolumnar reserve cells and other epithelia of human uterine cervix. Virchows Arch B 1987;54:98-110.
49. Marquez C, Trigueros C, Fernandez E, Tonbio ML. The development of T-cell and non-T-cell lineages from CD34(+) human thymic precursors can be traced by the differential expression of CD44. J Exp Med 1995;181:475-83.
50. Ikeda K, Nakao J, Asou H, Toya S, Shinoda J, Uyemura K. Expression of CD44H in the cells of neural crest origin in peripheral nervous system. Neuroreport 1996;7:1713-6.
51. Aguilera NSI, Chu WS, Andriko JAW, Abbondanzo SL. Expression of CD44 (HCAM) in small lymphocytic and mantle cell lymphoma. Hum Pathol 1998;29:1134-9.